XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Information by Segment (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenue from External Customer [Line Items]      
Cash-based $ 108,731 $ 214,735  
Stock-based 99,738 102,927  
Patent and licensing legal and filing fees and costs 56,084 83,211  
Other consulting and professional fees 205,315 172,443  
Insurance expense 64,277 126,854  
Other costs and expenses, net 81,338 147,645  
Total general and administrative costs 615,483 847,815  
Total 91,457 119,064  
Total assets 1,514,228   $ 1,145,503
Research And Development [Member]      
Revenue from External Customer [Line Items]      
Total assets 29,669   39,298
Corporate Segment [Member]      
Revenue from External Customer [Line Items]      
Total assets 1,484,559   $ 1,106,205
UNITED STATES      
Revenue from External Customer [Line Items]      
Total 58,571 34,583  
SPAIN      
Revenue from External Customer [Line Items]      
Total 32,886 15,234  
CHINA      
Revenue from External Customer [Line Items]      
Total 2,282  
NETHERLANDS      
Revenue from External Customer [Line Items]      
Total 66,965  
Clinical And Related Oversight Costs [Member]      
Revenue from External Customer [Line Items]      
Total 15,868 10,030  
Preclinical Research [Member]      
Revenue from External Customer [Line Items]      
Total 42,770 104,480  
Compound Maintenance [Member]      
Revenue from External Customer [Line Items]      
Total 32,819 3,894  
Regulatory Service Costs [Member]      
Revenue from External Customer [Line Items]      
Total $ 660